S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

(DDXS) Stock Forecast, Price & News

0.00 (0.00 %)
(As of 12/7/2020)
Today's Range
Now: $0.00
50-Day Range N/A
52-Week Range
Now: $0.00
Volume30 shs
Average Volume15,481 shs
Market Capitalization$410.00
P/E RatioN/A
Dividend YieldN/A
Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.
(DDXS) logo


Overall MarketRank

0.52 out of 5 stars

Health Technology Sector

9th out of 18 stocks

Biotechnology Industry

43rd out of 88 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Current SymbolOTCMKTS:DDXS
Phone(650) 246-6400



Sales & Book Value

Annual SalesN/A



Market Cap$410.00
Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 12/7/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive DDXS News and Ratings via Email

Sign-up to receive the latest news and ratings for DDXS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

(DDXS) (OTCMKTS:DDXS) Frequently Asked Questions

What stocks does MarketBeat like better than (DDXS)?

Wall Street analysts have given (DDXS) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (DDXS) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were (DDXS)'s earnings last quarter?

(DDXS) (OTCMKTS:DDXS) released its quarterly earnings results on Monday, October, 26th. The company reported ($0.34) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.69) by $0.35.
View (DDXS)'s earnings history

Who are some of (DDXS)'s key competitors?

What other stocks do shareholders of (DDXS) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (DDXS) investors own include GoPro (GPRO), General Electric (GE), Ambarella (AMBA) and Alliqua Biomedical (ALQA).

Who are (DDXS)'s key executives?

(DDXS)'s management team includes the following people:
  • Kenneth Charles Fang, Chief Medical Officer
  • Amy Figueroa, Head-Investor Relations

What is (DDXS)'s stock symbol?

(DDXS) trades on the OTCMKTS under the ticker symbol "DDXS."

How do I buy shares of (DDXS)?

Shares of DDXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is (DDXS)'s stock price today?

One share of DDXS stock can currently be purchased for approximately $0.00.

How big of a company is (DDXS)?

(DDXS) has a market capitalization of $410.00.

What is (DDXS)'s official website?

The official website for (DDXS) is www.diadexus.com.

How can I contact (DDXS)?

(DDXS)'s mailing address is 349 Oyster Point Blvd, SOUTH SAN FRANCISCO, CA 94080-1947, United States. The company can be reached via phone at (650) 246-6400.

This page was last updated on 1/23/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.